Evidence map›Paper›PMID 40985716›Full record

ArticleMicrobiology spectrum2025

Comparison of respiratory pathogen infections in hospitalized patients before and during the COVID-19 pandemic in Shanghai, China.

Xiaoxiao Li, Jie Wang, Junhua Dai, Fenfen Xiang, Zixi Chen, Mengzhe Zhang, Jiawen Qian, Rong Wu

Abstract readComparative Study
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaoxiao Li *Laboratory Medicine Department, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.ORCID 0000-0001-9729-1550
Jie Wang *Laboratory Medicine Department, Xundian County First People's Hospital, Kunming, China.
Junhua DaiLaboratory Medicine Department, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Fenfen XiangLaboratory Medicine Department, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zixi ChenLaboratory Medicine Department, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Mengzhe ZhangLaboratory Medicine Department, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Jiawen QianLaboratory Medicine Department, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Rong WuLaboratory Medicine Department, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.ORCID 0009-0005-1773-0362

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to assess the impact of COVID-19 on the prevalence of respiratory pathogens among hospitalized patients with respiratory tract infections in Shanghai, China. Patients with acute respiratory infections (ARIs) hospitalized at Putuo Hospital, Shanghai University of Traditional Chinese Medicine from January 2017 to December 2022 were collected. Indirect immunofluorescence assay (IFA) was used to detect the IgM antibody of nine common pathogens, including This study leverages the changes in the common respiratory spectrum pre-pandemic and during the COVID-19 pandemic in hospitalized patients in Shanghai. These data may serve as a scientific foundation for the prevention and management of ARIs. Doctors and policymakers should pay attention to the changes in the epidemic trends and types of respiratory pathogens and maintain monitoring of respiratory pathogens to better control the prevalence of respiratory pathogens.

Indexed as

COVID-19Respiratory Tract InfectionsAdolescentAdultAgedAged, 80 and overChildChild, PreschoolChinaFemaleHospitalizationHumansInfantMaleMiddle AgedPrevalenceacute respiratory infectionsCOVID-19hospitalizationrespiratory pathogens

Identifiers

PMID40985716
PMCPMC12584705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.